FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201848827> ?p ?o ?g. }

• W3201848827 endingPage "314" @default.
• W3201848827 startingPage "305" @default.
• W3201848827 abstract "To detect the prevalence of hyperuricemia in Egyptian rheumatoid arthritis (RA) patients as well as to assess its association with the severity of joint inflammation and disease-modifying antirheumatic drugs (DMARDs) in those patients.A total of 150 RA patients were recruited; all patients were subjected to (1) clinical and functional assessment by disease activity score in 28 joints (DAS28) and modified health assessment questionnaire (MHAQ). (2) Laboratory investigations: serum uric acid (SUA) level, complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), tumor necrosis factor α (TNF-α), interleukin 1 (IL1), and interleukin 6 (IL6) levels. (3) Radiological evaluation: (A) plain X-ray of both hands and feet; (B) musculoskeletal ultrasound (MSUS) of both wrists, hands, shoulder, ankle, and knee joints.SUA was significantly correlated with disease activity by DAS28. Acute-phase reactants and inflammatory markers (IL1β, IL6, and TNF-α) were also significantly elevated in RA patients with low and high hyperuricemia compared to those with normal SUA. A total of 90% of RA patients with low hyperuricemia had synovial proliferation with power Doppler (1+ and 2+), and 30 patients had mild effusion (1+), while nearly all patients with high hyperuricemia had hypoechoic synovial proliferation (2+ and 3+), and 20 patients had moderate effusion. However, 70% RA patients with normal serum uric acid showed mild synovitis and effusion (1+). No significant association was found between the administered DMARDs and levels of SUA as well as inflammatory markers; however, high-dose steroid treatment was associated with high SUA level.Elevation of serum uric acid levels in Egyptian RA patients was prevalent and might be an inflammatory marker for severity of joint inflammation. Moreover, higher doses of steroids could be considered a cause of hyperuricemia." @default.
• W3201848827 created "2021-10-11" @default.
• W3201848827 creator A5000045564 @default.
• W3201848827 creator A5013552552 @default.
• W3201848827 creator A5042530296 @default.
• W3201848827 creator A5045430029 @default.
• W3201848827 creator A5078760079 @default.
• W3201848827 date "2021-10-01" @default.
• W3201848827 modified "2023-09-26" @default.
• W3201848827 title "Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study" @default.
• W3201848827 cites W1608831349 @default.
• W3201848827 cites W1963700573 @default.
• W3201848827 cites W1963709354 @default.
• W3201848827 cites W1964439201 @default.
• W3201848827 cites W1975650161 @default.
• W3201848827 cites W1985749449 @default.
• W3201848827 cites W1989924068 @default.
• W3201848827 cites W2005085195 @default.
• W3201848827 cites W2009265650 @default.
• W3201848827 cites W2025372788 @default.
• W3201848827 cites W2029668562 @default.
• W3201848827 cites W2033635014 @default.
• W3201848827 cites W2036163062 @default.
• W3201848827 cites W2050928917 @default.
• W3201848827 cites W2051759477 @default.
• W3201848827 cites W2057163533 @default.
• W3201848827 cites W2058006546 @default.
• W3201848827 cites W2078856742 @default.
• W3201848827 cites W2082408635 @default.
• W3201848827 cites W2087037896 @default.
• W3201848827 cites W2101467420 @default.
• W3201848827 cites W2103494607 @default.
• W3201848827 cites W2106403351 @default.
• W3201848827 cites W2110177517 @default.
• W3201848827 cites W2110826367 @default.
• W3201848827 cites W2114518066 @default.
• W3201848827 cites W2128952811 @default.
• W3201848827 cites W2145612945 @default.
• W3201848827 cites W2146841820 @default.
• W3201848827 cites W2147978034 @default.
• W3201848827 cites W2151834039 @default.
• W3201848827 cites W2156444818 @default.
• W3201848827 cites W2163736657 @default.
• W3201848827 cites W2167491049 @default.
• W3201848827 cites W2183169666 @default.
• W3201848827 cites W2200509731 @default.
• W3201848827 cites W2335606186 @default.
• W3201848827 cites W2472948481 @default.
• W3201848827 cites W2560600951 @default.
• W3201848827 cites W2599076725 @default.
• W3201848827 cites W2606568709 @default.
• W3201848827 cites W2609852132 @default.
• W3201848827 cites W2743905759 @default.
• W3201848827 cites W2791155957 @default.
• W3201848827 cites W2944758259 @default.
• W3201848827 cites W4248614430 @default.
• W3201848827 cites W4294116629 @default.
• W3201848827 doi "https://doi.org/10.2147/oarrr.s331488" @default.
• W3201848827 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8502065" @default.
• W3201848827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34675698" @default.
• W3201848827 hasPublicationYear "2021" @default.
• W3201848827 type Work @default.
• W3201848827 sameAs 3201848827 @default.
• W3201848827 citedByCount "3" @default.
• W3201848827 countsByYear W32018488272022 @default.
• W3201848827 countsByYear W32018488272023 @default.
• W3201848827 crossrefType "journal-article" @default.
• W3201848827 hasAuthorship W3201848827A5000045564 @default.
• W3201848827 hasAuthorship W3201848827A5013552552 @default.
• W3201848827 hasAuthorship W3201848827A5042530296 @default.
• W3201848827 hasAuthorship W3201848827A5045430029 @default.
• W3201848827 hasAuthorship W3201848827A5078760079 @default.
• W3201848827 hasBestOaLocation W32018488271 @default.
• W3201848827 hasConcept C126322002 @default.
• W3201848827 hasConcept C141071460 @default.
• W3201848827 hasConcept C163430725 @default.
• W3201848827 hasConcept C2776232647 @default.
• W3201848827 hasConcept C2776914184 @default.
• W3201848827 hasConcept C2777575956 @default.
• W3201848827 hasConcept C2778143017 @default.
• W3201848827 hasConcept C2779244835 @default.
• W3201848827 hasConcept C2779721657 @default.
• W3201848827 hasConcept C2779881121 @default.
• W3201848827 hasConcept C2780402116 @default.
• W3201848827 hasConcept C2781195455 @default.
• W3201848827 hasConcept C71924100 @default.
• W3201848827 hasConcept C90924648 @default.
• W3201848827 hasConceptScore W3201848827C126322002 @default.
• W3201848827 hasConceptScore W3201848827C141071460 @default.
• W3201848827 hasConceptScore W3201848827C163430725 @default.
• W3201848827 hasConceptScore W3201848827C2776232647 @default.
• W3201848827 hasConceptScore W3201848827C2776914184 @default.
• W3201848827 hasConceptScore W3201848827C2777575956 @default.
• W3201848827 hasConceptScore W3201848827C2778143017 @default.
• W3201848827 hasConceptScore W3201848827C2779244835 @default.
• W3201848827 hasConceptScore W3201848827C2779721657 @default.
• W3201848827 hasConceptScore W3201848827C2779881121 @default.
• W3201848827 hasConceptScore W3201848827C2780402116 @default.

• next